Apraize 30 Tablet
By Apraize
Rx
10 Tablet in a Strip

Composition
Apremilast(30mg)

Manufacturer - Ipca Laboratories Ltd
142 AB, Kandivli Industrial Estate, Kandivli (West), Mumbai - 400 067, Maharashtra

Expires on or after
October, 2025

liver
Apraize 30 Tablet is considered safe for use in patients with liver disease. It is not necessary to adjust the dosage of Apraize 30 Tablet for individuals with liver issues. This means that patients with liver problems can generally take this medication without needing special considerations due to their liver condition. It is important to follow the prescribed dosage as instructed by your healthcare provider. Make sure to inform your doctor about any liver conditions you may have before starting Apraize 30 Tablet to ensure proper monitoring and management of your health.

kidney
Apraize 30 Tablet should be used cautiously in individuals with severe kidney disease. Dosage adjustment may be necessary, so it is important to seek advice from your healthcare provider.

alcohol
Caution is advised when consuming alcohol with Apraize 30 Tablet. It is important to consult your doctor before drinking alcohol while taking this medication.

driving
When taking Apraize 30 Tablet, it is uncertain if driving ability is affected. Avoid driving if you have symptoms that impact focus and reaction time.

pregnancy
Apraize 30 Tablet is considered unsafe during pregnancy due to potential harmful effects on the developing baby. Limited human studies are available, but animal studies indicate this risk. Your doctor will assess the benefits and risks before prescribing. Consult your doctor regarding its use.

breastfeeding
It is better to consult your doctor before using Apraize 30 Tablet.
Habit Forming | No |
Chemical Class | Isoindole Derivative |
Therapeutic Class | PAIN ANALGESICS |
Action Class | - |
₹357.3
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024